An international study of intrachromosomal amplification of chromosome 21 (iAMP21): cytogenetic characterization and outcome.
about
New and emerging prognostic and predictive genetic biomarkers in B-cell precursor acute lymphoblastic leukemiaEmerging technologies in paediatric leukaemiaDiagnosis and subclassification of acute lymphoblastic leukemiaAntigen-based immunotherapy for the treatment of acute lymphoblastic leukemia: the emerging role of blinatumomabChildhood acute lymphoblastic leukemia: Integrating genomics into therapyIntegration of cytogenomic data for furthering the characterization of pediatric B-cell acute lymphoblastic leukemia: a multi-institution, multi-platform microarray studyChildhood B-acute lymphoblastic leukemia: a genetic update.Intrachromosomal amplification of chromosome 21 in Korean pediatric patients with B-cell precursor acute lymphoblastic leukemia in a single institution.Treatment of adolescent and young adults with acute lymphoblastic leukemiaEvaluation of multiplex ligation dependent probe amplification (MLPA) for identification of acute lymphoblastic leukemia with an intrachromosomal amplification of chromosome 21 (iAMP21) in a Brazilian population.Diagnosis of intrachromosomal amplification of chromosome 21 (iAMP21) by molecular cytogenetics in pediatric acute lymphoblastic leukemiaThe RUNX Genes as Conditional Oncogenes: Insights from Retroviral Targeting and Mouse Models.Cytogenetic and Molecular Findings in Children with Acute Lymphoblastic Leukemia: Experience of a Single Institution in Argentina.Determination of ETV6-RUNX1 genomic breakpoint by next-generation sequencing.Frequency and Clinical Characteristics of Intrachromosomal Amplification of Chromosome 21 in Korean Childhood B-lineage Acute Lymphoblastic LeukemiaThe role of the RAS pathway in iAMP21-ALL.Coexistence of iAMP21 and ETV6-RUNX1 fusion in an adolescent with B cell acute lymphoblastic leukemia: literature review of six additional cases.Novel methods and approaches to acute lymphoblastic leukemia drug discovery.Risk factors for relapse in childhood acute lymphoblastic leukemia: prediction and prevention.The RUNX family: developmental regulators in cancer.Genomics in acute lymphoblastic leukaemia: insights and treatment implications.Cytogenetic Variation of B-Lymphoblastic Leukemia With Intrachromosomal Amplification of Chromosome 21 (iAMP21): A Multi-Institutional Series Review.Treatment of Childhood Acute Lymphoblastic Leukemia: Prognostic Factors and Clinical Advances.Genomic characterization of paediatric acute lymphoblastic leukaemia: an opportunity for precision medicine therapeutics.Correlates of Prenatal and Early-Life Tobacco Smoke Exposure and Frequency of Common Gene Deletions in Childhood Acute Lymphoblastic Leukemia.Comparison of clinical trial versus non-clinical trial treatment outcomes of childhood acute lymphoblastic leukemia using comparable regimens.A risk score including microdeletions improves relapse prediction for standard and medium risk precursor B-cell acute lymphoblastic leukaemia in children.Dynamic clonal progression in xenografts of acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21.B-cell lymphoblastic lymphoma presenting as solitary temporal mass with amplification of AML1/RUNX1: case report.Prognostic impact of RUNX1 and ETV6 gene copy number on pediatric B-cell precursor acute lymphoblastic leukemia with or without hyperdiploidy.Acute lymphoblastic leukaemiaAcute lymphoblastic leukemia
P2860
Q26749177-347531FD-13C6-470C-AA0C-CEB7E4C45760Q26770327-8EE7EF6B-CE90-4B12-B03B-1D8D0CE84C76Q26824387-277B68B1-0688-4032-AF9B-FF228476473FQ27013710-460CF5EA-38FB-4C79-AD26-AC7D4F1E9489Q28080463-1874D7BD-3A25-4448-9407-91262AAC23D5Q30842603-8DBC9D43-E600-4FA0-88BA-381EF5773F25Q33777616-1904ED9D-5650-49F6-B262-10560E49F0F5Q33889940-DE0E9441-6B11-4D85-8303-D6E79263C764Q33920153-1CAE0686-85C3-4FC7-8699-CFAF77EDB023Q35701004-53F1CDF5-9F17-43E3-A1CE-BF03BFCD604EQ36188346-71B66C3A-57C4-4120-8C12-9EE748C67664Q36309953-94E20F7D-329F-4E0A-B357-D057483A912CQ36325830-E95F9659-86B0-44B6-91B0-075D48CF33CDQ36528412-F5810A9E-BBB0-4C7D-B237-3634A4155D42Q37084156-563149FF-EFD1-4C95-AC8E-870B1E06FDD1Q37245131-D80621A5-4702-4E31-95F6-CF403003944FQ37426281-D1CC2748-0B3F-4FF6-A4FC-281BF76316B5Q38248461-8196CFEE-BF3B-4854-9FD1-D8160AE55418Q38264774-C47D1515-B88F-4FAF-95B4-A53F673621A2Q38319972-DD38E5BD-0B1F-400F-B02B-93100353F133Q38381463-341721DB-33FD-47DB-920B-C1ADCDA438E3Q38526944-3B0C504C-B95F-4334-8CC6-0EAB90FCEC8EQ38922016-F2A1A1DE-470D-47F6-B8AE-0EE06DEF360AQ39041475-032A3425-AA74-456E-AC5E-99ADDABB1DE0Q40334470-9C4BC7C1-4E7D-4321-A6A3-9954BE607636Q40895560-84277F7F-281E-4F5F-A70A-2632113A194BQ47203054-06185C72-F283-4916-9D8D-21C94AF0A93BQ49959951-B085FD97-53CE-4391-90BD-11F32D19385CQ49966368-4D6655D0-6275-4B2B-9F2E-0ED773D9A78CQ51653753-A8AB7AE6-0F51-43D4-9BF1-BF9B4310F9EDQ58481753-ADC1C44D-567F-46CB-BE5E-38FD4B84C58CQ58481759-521998C7-5D08-4E44-9FAB-07D3C919D937
P2860
An international study of intrachromosomal amplification of chromosome 21 (iAMP21): cytogenetic characterization and outcome.
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
An international study of intr ...... characterization and outcome.
@ast
An international study of intr ...... characterization and outcome.
@en
An international study of intrachromosomal amplification of chromosome 21
@nl
type
label
An international study of intr ...... characterization and outcome.
@ast
An international study of intr ...... characterization and outcome.
@en
An international study of intrachromosomal amplification of chromosome 21
@nl
prefLabel
An international study of intr ...... characterization and outcome.
@ast
An international study of intr ...... characterization and outcome.
@en
An international study of intrachromosomal amplification of chromosome 21
@nl
P2093
P2860
P50
P356
P1433
P1476
An international study of intr ...... characterization and outcome.
@en
P2093
A Attarbaschi
A Baruchel
A J Carroll
A Teigler-Schlegel
C Haferlach
E Forestier
P2860
P2888
P304
P356
10.1038/LEU.2013.317
P50
P577
2013-10-29T00:00:00Z
P5875
P6179
1000760190